AFRM three-lens brief
Evidence-based stock research on AFRM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price down 7.84% in the last session — a material single-day move. · Debt-to-equity of 240.3 — balance-sheet-heavy.
- Price down 7.84% in the last session — a material single-day move.
- Outperforming SPY by 18.4pp over 30 days.
- Analyst mean target $82.34 — 37% above current (27 analysts).
- Debt-to-equity of 240.3 — balance-sheet-heavy.
- Reported earnings on 2026-05-07.
AFRM closed at $60.30 (-7.84%) as of 2026-05-13. Market cap: $20.19B. P/E (trailing) 54.8. Positives: outperforming SPY by 18.4pp over 30 days.; analyst mean target $82.34 — 37% above current (27 analysts).. Concerns: price down 7.84% in the last session — a material single-day move.; debt-to-equity of 240.3 — balance-sheet-heavy.. Last quarter: Revenue $1.04B, net income $102.90M, free cash flow $301.09M.
Why three lenses on AFRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AFRMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AFRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AFRM brief"></iframe>